tiprankstipranks
Trending News
More News >
Appili Therapeutics Inc Class A (APLIF)
OTHER OTC:APLIF
US Market

Appili Therapeutics Inc Class A (APLIF) Income Statement

Compare
82 Followers

Appili Therapeutics Inc Class A Income Statement

Last quarter (Q3 2026), Appili Therapeutics Inc Class A's total revenue was C$114.98K, an increase of 6.11% from the same quarter last year. In Q3, Appili Therapeutics Inc Class A's net income was C$-949.50K. See Appili Therapeutics Inc Class A’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 20Jun 19
Total Revenue
C$ 100.44KC$ 334.18KC$ 1.39MC$ 0.00C$ 199.11K
Gross Profit
C$ 100.44KC$ 327.91KC$ 1.39MC$ -14.84KC$ 199.11K
Operating Expenses
C$ 291.28KC$ 8.11MC$ 24.95MC$ 16.28MC$ 5.60M
Depreciation and Amortization
C$ 13.46KC$ 6.27KC$ 12.64KC$ 14.84KC$ 17.75K
EBITDA
C$ 360.57KC$ -8.10MC$ -23.51MC$ -14.87MC$ -5.63M
Operating Income
C$ -190.84KC$ -7.91MC$ -24.68MC$ -16.30MC$ -6.13M
Other Income/Expenses
C$ -2.42MC$ -1.29MC$ -401.36KC$ 1.34MC$ 28.06K
Pretax Income
C$ -2.61MC$ -9.21MC$ -25.08MC$ -14.95MC$ -5.42M
Net Income
C$ -2.62MC$ -9.24MC$ -25.12MC$ -14.33MC$ -5.42M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.08C$ -0.38C$ -0.24C$ -0.16
Diluted EPS
C$ -0.02C$ -0.08C$ -0.38C$ -0.24C$ -0.16
Weighted Average Shares Outstanding
121.27M 113.73M 66.73M 59.18M 34.33M
Weighted Average Shares Outstanding (Diluted)
121.27M 113.73M 66.73M 59.18M 34.33M
Currency in CAD

Appili Therapeutics Inc Class A Earnings and Revenue History